ABEO
Abeona Therapeutics Inc
Halal Rating :
Last Price
$5.21
Last updated:
Market Cap
-
7D Change
-7.13%
1 Year Change
2.56%
Company Overview
Industries
Exchange
Next Earnings Date
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company developing gene and cell therapies for life-threatening rare genetic diseases. Their main focus is on developing treatments for recessive dystrophic epidermolysis bullosa (RDEB) and other rare genetic diseases. The company's lead product candidate is EB-101, a gene-corrected cell therapy for RDEB.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|
Company Impact
Help us evaluate Abeona Therapeutics Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.